Curi Updates Vaccine Booster and Monoclonal Antibody Treatment Consent Forms to Reflect Expanded Age Groups

The Curi team has updated our COVID-19 vaccine booster consent form to reflect Emergency Use Approval of the Pfizer vaccine for 16- and 17-year-olds. The form is available here. We have also updated our monoclonal antibody treatment consent form to include the FDA’s approval of use for younger pediatric patients, including newborns. That form is available here.

News & Knowledge
All Curi recommendations are based on current CDC criteria at the time of publication. CDC guidance for SARS-CoV-2 infection may, or may not, be adopted by state and local health departments to respond to rapidly changing local circumstances. Providers should always check with their local health department to see if the CDC’s guidance on any given topic has been modified (particularly if more restrictive) from the CDC’s recommended guidelines. Follow this link https://www.cdc.gov/publichealthgateway/healthdirectories/index.html for contact information to your state/local health department. If local recommendations vary from those of the CDC, and you are unsure what recommendations to follow, then it is safer to follow the more restrictive guidelines/recommendations.